|
|
|
|
|
HOME >
CORPORATE INFO > CORPORATE ANNOUNCEMENTS
|
|
|
|
|
|
15-05-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet |
|
|
|
|
|
14-05-2024
|
|
|
|
| GLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 24-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
|
|
|
|
|
14-05-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
|
|
14-05-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange about Closure of Trading Window |
|
|
|
|
|
10-05-2024
|
|
|
|
| Intimation of (i) Securities Subscription & Shareholders Agreement between Glenmark Pharmaceuticals Limited and O2 Renewable Energy XXIV Private Limited and O2 Energy SG PTE Limited AND (ii) Power Purchase Agreement between Glenmark Pharmaceuticals Limit |
|
|
|
|
|
10-05-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange regarding Acquisition |
|
|
|
|
|
29-04-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 29, 2024, titled "Glenmark Pharmaceuticals receives ANDA approval forAcetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC)". |
|
|
|
|
|
25-04-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange about Credit Rating |
|
|
|
|
|
12-04-2024
|
|
|
|
| Glenmark Pharmaceuticals Limitedï¿‚ï¾ has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaï¿‚ï¾ (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
|
|
|
|
02-04-2024
|
|
|
|
| GLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
|
|
|
|
|
02-04-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange about Retirement |
|
|
|
|
|
21-03-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange about Credit Rating |
|
|
|
|
|
14-03-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange about Credit Rating |
|
|
|
|
|
13-03-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange about Credit Rating |
|
|
|
|
|
13-03-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure pursuant to Regulation 30(7) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'. |
|
|
|
|
|
12-03-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure pursuant to Regulation 30(7) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'. |
|
|
|
|
|
07-03-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure pursuant to Regulation 30(7) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'. |
|
|
|
|
|
06-03-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure pursuant to Regulation 30(7) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'. |
|
|
|
|
|
21-02-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange regarding Allotment of Securities |
|
|
|
|
|
20-02-2024
|
|
|
|
| Glenmark Pharmaceuticals Limited has informed the Exchange regarding Allotment of Securities |
|
|
|
|
|
|
|
|
|
|
|
|